Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2023	$ 125,704	$ 45	$ 411,821	$ 63	$ (286,225)
Beginning Balance, Shares at Dec. 31, 2023		44,754,853
Issuance of common stock in private placement, net of offering costs	39,172	$ 9	39,163
Issuance of common stock in private placement, net of offering costs (Shares)		8,849,371
Issuance of common stock pursuant to at-the-market (ATM) program, net of offering costs	10,590	$ 4	10,586
Issuance of common stock pursuant to at-the-market (ATM) program, net of offering costs (Shares)		3,600,000
Issuance of pre-funded warrants in private placement, net of offering costs	7,700		7,700
Issuance of restricted common stock, net of tax withholdings	(196)	$ 1	(197)
Issuance of restricted common stock, net of tax withholdings, (Shares)		1,497,921
Stock options exercised	245		245
Stock options exercised (Shares)		100,981
Stock-based compensation	4,320		4,320
Net unrealized loss on marketable debt securities	(123)			(123)
Net loss	(3,256)				(3,256)
Ending balance at Mar. 31, 2024	184,156	$ 59	473,638	(60)	(289,481)
Ending balance (in shares) at Mar. 31, 2024		58,803,126
Beginning balance at Dec. 31, 2023	125,704	$ 45	411,821	63	(286,225)
Beginning Balance, Shares at Dec. 31, 2023		44,754,853
Net unrealized loss on marketable debt securities	(165)
Net loss	(20,557)
Ending balance at Jun. 30, 2024	169,794	$ 59	476,619	(102)	(306,782)
Ending balance (in shares) at Jun. 30, 2024		58,914,712
Beginning balance at Mar. 31, 2024	184,156	$ 59	473,638	(60)	(289,481)
Beginning Balance, Shares at Mar. 31, 2024		58,803,126
Issuance of restricted common stock, net of tax withholdings	(43)		(43)
Issuance of restricted common stock, net of tax withholdings, (Shares)		30,553
Issuance of common stock under employee stock purchase plan ("ESPP")	105		105
Issuance of common stock under employee stock purchase plan ("ESPP") (Shares)		59,882
Stock options exercised	48		48
Stock options exercised (Shares)		21,151
Stock-based compensation	2,871		2,871
Net unrealized loss on marketable debt securities	(42)			(42)
Net loss	(17,301)				(17,301)
Ending balance at Jun. 30, 2024	169,794	$ 59	476,619	(102)	(306,782)
Ending balance (in shares) at Jun. 30, 2024		58,914,712
Beginning balance at Dec. 31, 2024	120,751	$ 60	484,077	170	(363,556)
Beginning Balance, Shares at Dec. 31, 2024		59,967,814
Exercise of pre-funded warrants	2	$ 2
Exercise of pre-funded warrants (Shares)		1,611,215
Issuance of restricted common stock, net of tax withholdings	(2)		(2)
Issuance of restricted common stock, net of tax withholdings, (Shares)		22,728
Issuance of common stock under employee stock purchase plan ("ESPP") (Shares)		29,619
Stock-based compensation	3,631		3,631
Net unrealized loss on marketable debt securities	(121)			(121)
Net loss	(21,158)				(21,158)
Ending balance at Mar. 31, 2025	103,103	$ 62	487,706	49	(384,714)
Ending balance (in shares) at Mar. 31, 2025		61,631,376
Beginning balance at Dec. 31, 2024	120,751	$ 60	484,077	170	(363,556)
Beginning Balance, Shares at Dec. 31, 2024		59,967,814
Net unrealized loss on marketable debt securities	(175)
Net loss	(39,512)
Ending balance at Jun. 30, 2025	87,643	$ 62	490,654	(5)	(403,068)
Ending balance (in shares) at Jun. 30, 2025		62,018,135
Beginning balance at Mar. 31, 2025	103,103	$ 62	487,706	49	(384,714)
Beginning Balance, Shares at Mar. 31, 2025		61,631,376
Issuance of restricted common stock, net of tax withholdings	(67)		(67)
Issuance of restricted common stock, net of tax withholdings, (Shares)		386,759
Stock-based compensation	3,015		3,015
Net unrealized loss on marketable debt securities	(54)			(54)
Net loss	(18,354)				(18,354)
Ending balance at Jun. 30, 2025	$ 87,643	$ 62	$ 490,654	$ (5)	$ (403,068)
Ending balance (in shares) at Jun. 30, 2025		62,018,135